CSPYX | FSSNX | CSPYX / FSSNX | |
Total Expense Ratio | 0.20 | 0.03 | 800% |
Annual Report Gross Expense Ratio | 0.20 | 0.03 | 800% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | -7.231 | 0.650 | -1,112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.55B | 25.9B | 10% |
Annual Yield % from dividends | 1.53 | 0.90 | 169% |
Returns for 1 year | -9.60 | 9.47 | -101% |
Returns for 3 years | -13.53 | 21.54 | -63% |
Returns for 5 years | 5.92 | 48.25 | 12% |
Returns for 10 years | N/A | 81.84 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WTID | 14.88 | 0.35 | +2.39% |
MicroSectors™ Energy -3X Invrs Lvrgd ETN | |||
SCHF | 22.20 | 0.18 | +0.82% |
Schwab International Equity ETF™ | |||
FFC | 16.31 | 0.03 | +0.18% |
Flaherty & Crumrine Preferred and Income Securities Fund | |||
FPAG | 34.06 | -0.02 | -0.07% |
FPA Global Equity ETF | |||
BIB | 50.23 | -1.29 | -2.50% |
ProShares Ultra Nasdaq Biotechnology |